ABT-773: a new ketolide antibiotic
- PMID: 11178346
- DOI: 10.1517/13543784.10.2.343
ABT-773: a new ketolide antibiotic
Abstract
ABT-773 is a new semisynthetic derivative of erythromycin A, the ketolide class of broad spectrum antibacterial agents, in Phase II development by Abbott. With good broad spectrum activity against Gram-positive, some Gram-negative organisms and intracellular bacteria, ABT-773 is being developed as a respiratory agent. Structural changes in the ketolide class agents such as ABT-773 provides expanded activity in vitro against macrolide-resistant strains of Streptococcus pneumoniae and improved activity against MLS(B) (macrolide-lincosamide-streptogramin) constitutive expressing streptococci.
Similar articles
-
Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.J Antimicrob Chemother. 2002 Jan;49(1):189-92. doi: 10.1093/jac/49.1.189. J Antimicrob Chemother. 2002. PMID: 11751787
-
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.Antimicrob Agents Chemother. 2001 Jul;45(7):2163-8. doi: 10.1128/AAC.45.7.2163-2168.2001. Antimicrob Agents Chemother. 2001. PMID: 11408246 Free PMC article.
-
Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.J Antimicrob Chemother. 2002 Dec;50(6):907-13. doi: 10.1093/jac/dkf237. J Antimicrob Chemother. 2002. PMID: 12461012
-
Recent developments on ketolides and macrolides.Curr Med Chem. 2001 Dec;8(14):1727-58. doi: 10.2174/0929867013371671. Curr Med Chem. 2001. PMID: 11562291 Review.
-
ABT-773 (Abbott Laboratories).Curr Opin Investig Drugs. 2001 Jun;2(6):766-72. Curr Opin Investig Drugs. 2001. PMID: 11572654 Review.
Cited by
-
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro.Antimicrob Agents Chemother. 2004 Apr;48(4):1096-104. doi: 10.1128/AAC.48.4.1096-1104.2004. Antimicrob Agents Chemother. 2004. PMID: 15047507 Free PMC article.
-
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z. Wien Klin Wochenschr. 2006. PMID: 17160604 Review.
-
Activities of ABT-773 against microaerophilic and fastidious organisms.Antimicrob Agents Chemother. 2002 Aug;46(8):2716-9. doi: 10.1128/AAC.46.8.2716-2719.2002. Antimicrob Agents Chemother. 2002. PMID: 12121965 Free PMC article.
-
Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach.Microorganisms. 2021 Dec 6;9(12):2518. doi: 10.3390/microorganisms9122518. Microorganisms. 2021. PMID: 34946123 Free PMC article. Review.
-
The In Vitro Antimicrobial Susceptibility of Borrelia burgdorferi sensu lato: Shedding Light on the Known Unknowns.Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204. Pathogens. 2023. PMID: 37887720 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical